Anna Maria Ierardi1, Francesca Giorlando1, Filippo Piacentino1, Federico Fontana1, Raffaele Novario2, Salvatore Alessio Angileri3, Ejona Duka1, Gianpaolo Carrafiello4. 1. Interventional Radiology, Department of Radiology, Insubria University, Viale Borri 57, 21100, Varese, VA, Italy. 2. Department of Biotechnology and Life Sciences Medical Physics, University Hospital of Varese, Viale Borri 57, 21100, Varese, VA, Italy. 3. Diagnostic and Interventional Radiology Unit, Department of Health Sciences, University of Milan, Viale A. di Rudinì 8, 20142, Milan, Italy. 4. Diagnostic and Interventional Radiology Unit, Department of Health Sciences, University of Milan, Viale A. di Rudinì 8, 20142, Milan, Italy. gcarraf@gmail.com.
Abstract
PURPOSE: The aim of our study was to evaluate factors influencing effectiveness of percutaneous microwave ablation (MWA) in patients with small hepatocellular carcinoma (HCC) (<3 cm). MATERIALS AND METHODS: Between December 2007 and August 2015, 49 patients with 65 previously histological typed HCC were treated in a total of 61 sessions. Tumours were subdivided into central (>3 cm from the capsule) (n = 22) and peripheral (<3 cm from the capsule) (n = 43). Imaging follow-up was performed at 1, 3, 6, and 12 months after treatment, then annually. Mean follow-up period was 18 months (range 1-55). Location of the lesion, age, sex, and underlying disease of the patients was analyzed and related with efficacy. RESULTS: Technical success was obtained in all cases. Residual disease was registered in 21 lesions (32.3 %): 13 were peripheral and 8 were central. Twelve of them were retreated with percutaneous MWA. Local recurrence was recorded in 8 lesions (12.3 %): 5 were retreated with MWA. No significant difference in terms of effectiveness was observed in lesions located in a central position and those situated in the peripheral position. Age, sex, and underlying disease not influenced results. Only one major complication was observed. The rate of minor complications was 24.5 %. Mortality at 30 days was 0 %. CONCLUSIONS: Our results encourage the role of MWA in the treatment of small HCC. More numerous series and randomized studies are necessary to state the role of MWA and to select cases in which MWA may be more effective and safer than RFA.
PURPOSE: The aim of our study was to evaluate factors influencing effectiveness of percutaneous microwave ablation (MWA) in patients with small hepatocellular carcinoma (HCC) (<3 cm). MATERIALS AND METHODS: Between December 2007 and August 2015, 49 patients with 65 previously histological typed HCC were treated in a total of 61 sessions. Tumours were subdivided into central (>3 cm from the capsule) (n = 22) and peripheral (<3 cm from the capsule) (n = 43). Imaging follow-up was performed at 1, 3, 6, and 12 months after treatment, then annually. Mean follow-up period was 18 months (range 1-55). Location of the lesion, age, sex, and underlying disease of the patients was analyzed and related with efficacy. RESULTS: Technical success was obtained in all cases. Residual disease was registered in 21 lesions (32.3 %): 13 were peripheral and 8 were central. Twelve of them were retreated with percutaneous MWA. Local recurrence was recorded in 8 lesions (12.3 %): 5 were retreated with MWA. No significant difference in terms of effectiveness was observed in lesions located in a central position and those situated in the peripheral position. Age, sex, and underlying disease not influenced results. Only one major complication was observed. The rate of minor complications was 24.5 %. Mortality at 30 days was 0 %. CONCLUSIONS: Our results encourage the role of MWA in the treatment of small HCC. More numerous series and randomized studies are necessary to state the role of MWA and to select cases in which MWA may be more effective and safer than RFA.
Entities:
Keywords:
Effectiveness; Factors predicting; Percutaneous microwave ablation; Small hepatocellular carcinoma
Authors: S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman; Luigi Solbiati; Thomas J Vogl; Bradford J Wood; Suresh Vedantham; David Sacks Journal: J Vasc Interv Radiol Date: 2009-07 Impact factor: 3.464
Authors: Francesco De Cobelli; Paolo Marra; Francesca Ratti; Alessandro Ambrosi; Michele Colombo; Anna Damascelli; Claudio Sallemi; Simone Gusmini; Marco Salvioni; Pietro Diana; Federica Cipriani; Massimo Venturini; Luca Aldrighetti; Alessandro Del Maschio Journal: Med Oncol Date: 2017-02-20 Impact factor: 3.064
Authors: Pierpaolo Biondetti; Enrico Maria Fumarola; Anna Maria Ierardi; Andrea Coppola; Giovanna Gorga; Luca Maggi; Elena Valconi; Salvatore Alessio Angileri; Gianpaolo Carrafiello Journal: Med Oncol Date: 2020-04-02 Impact factor: 3.064
Authors: Vincenza Granata; Roberta Grassi; Roberta Fusco; Sergio Venanzio Setola; Andrea Belli; Mauro Piccirillo; Silvia Pradella; Marzia Giordano; Salvatore Cappabianca; Luca Brunese; Roberto Grassi; Antonella Petrillo; Francesco Izzo Journal: Int J Environ Res Public Health Date: 2021-03-30 Impact factor: 3.390